Clemson University

TigerPrints
All Theses

12-2017

Improving Cell Seeding of Decellularized and
Porated Porcine Arterial Scaffolds
Harrison Smallwood
Clemson University

Follow this and additional works at: https://tigerprints.clemson.edu/all_theses
Recommended Citation
Smallwood, Harrison, "Improving Cell Seeding of Decellularized and Porated Porcine Arterial Scaffolds" (2017). All Theses. 2768.
https://tigerprints.clemson.edu/all_theses/2768

This Thesis is brought to you for free and open access by the Theses at TigerPrints. It has been accepted for inclusion in All Theses by an authorized
administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.

Theses

IMPROVING CELL SEEDING OF DECELLULARIZED AND PORATED PORCINE ARTERIAL
SCAFFOLDS
A Thesis
Presented to
the Graduate School of
Clemson University
In Partial Fulfillment
of the Requirements for the Degree
Master of Science
Bioengineering
by
Harrison Smallwood
December 2017
Accepted by:
Dr. Dan Simionescu, Committee Chair
Dr. Agneta Simionescu
Dr. Christopher Wright

ABSTRACT
Coronary artery disease is one of the number one killers in the U.S. Current
treatment of using CABG surgery has limitations from availability of autologous grafts,
and low patency of artificial grafts. Tissue engineered grafts would ideally provide more
availability, while also replicating the mechanical properties of the native grafts. Current
issues in tissue engineering arteries lie in using an effective scaffold to get correct
mechanical properties, and allowing for cell infiltration to assist in integrating with
native tissue once implanted. This study shows the use of a decellularized and
chemically and mechanically porated porcine carotid artery in mechanical
characterization and cell seeding experiments. The mechanical properties all exhibit
values like that of current autologous grafts. The cell seeding studies show data
determining the viability of these porated scaffolds in cell infiltration. It also examines
several seeding techniques and how they impact the location of cells. This study
concludes that the decellularization and poration procedures result in a scaffold with
suitable mechanical properties for CABG grafts. It also concludes that several different
cells seeding methods can be effective in getting cells onto the scaffold, but some work
remains on developing an ideal tissue.
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INTRODUCTION
Anatomy of the Heart
The heart is responsible for pumping blood to the lungs for oxygenation, then to
the rest of the body to provide nutrients and oxygen to tissue. The heart has 4
chambers, left and right atrium, and left and right ventricle. Blood flows into the heart

Figure 1: A) location and orientation of heart in average person. B) Cross section of heart, identifying major features of
the heart, and displaying direction of blood flow. (National Heart, Lung, and Blood Institute, 2015)

through the vena cava then into right atrium then right ventricle into pulmonary artery
to lungs. Then it goes into pulmonary vein left atrium then left ventricle. The heart
controls the blood flow into its chambers and surrounding vessels using 4 valves;
pulmonary, mitral, aortic, and tricuspid. (National Heart, Lung, and Blood Institute,
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2015) The left ventricle is thicker and pumps harder so it can deliver blood to the rest of
the body. Immediately after the blood leaves the left ventricle I enters the aorta, which
has 2 small branches immediately after the valve that go to the coronary arteries, which
are responsible for vascularizing the outer layers of the heart.

Stats on CAD and Heart Disease
Heart disease is an issue of paramount importance in the US. It’ the then number
one killer of both men and women, causing over half of male deaths in 2009. 610,000
Americans die every year from heart disease. (Centers for Disease Control, 2015) The
costs of heart disease, both direct and indirect, is around $199.6 billion a year.
(American Heart Association, 2017) High blood pressure, high LDL cholesterol and
smoking are 3 of the biggest risk factors for heart disease, and almost half of Americans
have at least one of these factors (Fryar, Chen, & Li, 2012). Heart disease mainly affects
older patients, but as many as 4-10% of heart attacks occur before the age of 45.
(Harvard Medical School, 2009)

What is CAD?
Coronary Artery Disease (CAD) is the most prevalent type of heart disease,
responsible for the deaths of 370,000 people annually. (Centers for Disease Control,
2015) CAD is caused by buildup of plaque on the inner walls of the coronary artery,
which provides blood flow and oxygen to the heart itself. This is known as
atherosclerosis. The plaque buildup effectively narrows the artery restricting the blood
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flow, leading to the patient suffering ischemia or heart attack without treatment. With
time CAD can weaken the muscles of the heart leading to heart failure or arrhythmias.
(National Heart, Lung, and Blood Institute, 2016)

Progression
The coronary artery has 3 layers: the tunica intima composed of endothelial cells
and (in contrast to many other mammals) a thin layer of smooth muscle cells. The tunica
media is composed of smooth muscle cells in a complex extracellular matrix containing

Elastin, the tunica adventitia is composed of fibroblasts and collagen and elastin
(Nemeno-Guanzon, et al., 2012). Atherogenesis begins initially with leukocytes binding
to the endothelial monolayer then migrating inward. The monocytes begin to mature
into macrophages, and then through uptake of lipids, become foam cells. (Hansson,
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2005)

Figure 2: progression of atherosclerosis over a patient’s lifetime. (Della Rocca & Pepine, 2010)

Intimal migration of medial SMCs occurs, coupled with increased proliferation of
medial and intimal SMCs inside the intimal layer. There is also more production of
collagen, elastin, and proteoglycans. SMCs and macrophages can die in this
environment, and often their contents end up trapped in what is known as the necrotic
core. All of this leads to narrowing of the artery and eventual occlusion through
thrombosis, when the fibrous cap becomes loose and is released into the lumen. (Libby,
Ridker, & Hansson, 2011)
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Current treatments
The two main treatments for CAD consist of percutaneous coronary intervention
(PCI), and coronary artery bypass graft surgery (CABG). PCI is a noninvasive surgery that
places a stent where the blockage in the artery is, opening the lumen of the coronary,
and allowing free flow of blood. CABG is an invasive open-heart surgery where a using a
graft (using an autologous artery/vein from elsewhere in body, or from a cadaver, or
synthetic or tissue engineered vessels.) the blocked portion of the artery is completely
bypassed and blood flow is diverted through the new vessels instead. (National Heart,
Lung, and Blood Institute, 2012)

Figure 3: A) Shows the location of the heart B) Shows location of bypass grafts after CABG surgery (National Heart,
Lung, and Blood Institute, 2012)
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CABG has increased reduction in myocardial infarctions, and is considered a
better option for multi-vessel CAD. For patients, unable to withstand the trauma of
open-heart surgery, CABG may not be a viable option. Minimally invasive CABG surgery
is possible and has been in use since late 90’s early 2000’s, but requires a complex
system for the operations that many surgeons aren’t trained on, and requires a very
long learning curve. (Diodato & Chedrawy, 2014) There is also an issue in suitable grafts
for CABG surgery. The most commonly grafted blood vessels are the internal mammary
artery and the saphenous vein, but who experience atherosclerosis in their coronary
artery commonly have it developing in other blood vessels that would otherwise be
suitable grafts. Patients who must undergo multiple bypass surgeries are at even greater
disadvantage because they may have suitable autologous grafts for one or two grafts
but not the rest. (Pashneh-Tala, Macneil, & Claeyssens, 2016) Synthetic scaffolds have
proven to be viable alternatives for large and medium diameter arteries, but suffer from
poor patency in small diameter arteries. (Pashneh-Tala, Macneil, & Claeyssens, 2016).
Much of the poor patency may result from mismatched compliance of the graft and
native tissue, lack of or damaged endothelial cells, trauma from surgery, and
hemodynamic factors. (Pashneh-Tala, Macneil, & Claeyssens, 2016)
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Tissue Engineering Paradigm
The tissue engineering paradigm consists of taking a patient’s cells, isolating the
desired cell type(s), cell proliferation and then seeding on some type of scaffold then

Figure 4: Overview of tissue engineering paradigm, depicting cell isolation form a patient, cultivation, and
proliferation of those cells, developing those cells into a tissue in conjunction with a scaffold, then implanting the
tissue into a now healthy patient (Killian, Cavinatto, Galatz, & Thomopoulos, 2012)

implantation into the body. Scaffolds can be artificial, allogeneic, or xenogeneic, but are
usually chosen to be biodegradable, biocompatible, and having similar mechanical
properties as the tissue that they replace. There is evidence of graft mechanical
properties being modified sometime after implantation due to effects of vascular
integration. (Pashneh-Tala, Macneil, & Claeyssens, 2016)
The methods by which grafts integrate into an animal or human host isn’t
obvious. Neutrophils and monocytes from the host are suspected to be involved, but it’s
not clear how, and to what degree a graft preseeded with cells would interact with
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them and affect this process. There are many unanswered questions when it comes to
tissue engineering, the best cell types, scaffold materials, scaffold structure, and cell
integration methods are still being determined. Proper graft hemodynamics may have
an effect on vascular integration and calcification rates, and can’t be ignored. As tissue
engineering continues to develop, more clinical use and improved understanding of
what’s needed for an effective graft will lead to commercially viable grafts. (PashnehTala, Macneil, & Claeyssens, 2016)

Scaffolds
Scaffolds can be made from a variety of materials (PLA, PGA, collagen, silk,
chitosan, among many others) in a variety of manners (electrospinning, 3d printing, gels,
decellularized xenogeneic tissue) (Nemeno-Guanzon, et al., 2012). Scaffolds ideally
should have similar compliance and burst pressure as a coronary artery, or saphenous
vein or internal mammary artery (the most common autologous grafts). There has been
incredible variety in the materials proposed for scaffolds, the cells used to seed them,
and the ways that the tests were quantified making. Some have favored an approach
using no scaffolds, instead relying on the extracellular matrix the cells are capable of
naturally producing. (Nemeno-Guanzon, et al., 2012) The architecture of the scaffold
should have a porated structure to allow for cell infiltration, and for adequate nutrient
diffusion to the cells that migrate inward. Scaffolds must also be biocompatible, as any
material that would cause rejection is unacceptable. For scaffolds to be commercially
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viable and have the most impact in the treatment of medicine, they need to be able to
be scaled up to mass production. (O'Brien, 2011)

Stem Cells
One of stem cells most popular uses are in the fields of regenerative medicine
and tissue engineering. Stem cells are unspecialized cells have the unique ability to
develop and change into a wide variety of cell types. There are 3 existing types of stem
cells, Adult Stem Cells (ASC), embryonic Stem cells (ESC), and induced pluripotent stem
cells (iPSC). ASCs are present throughout the body in very small numbers, but are most
easily obtained through bone marrow or adipose tissue. The cells can differentiate into
the cell types of the tissue they reside in. (i.e. hematopoietic stem cells won’t develop
into neurons, but can differentiate into the various types of blood cells). iPSCs are
genetically modified stem cells, created by altering the gene expression of normal cells,
reverting them back to a stem cell, capable of differentiation into cell types of all 3 germ
layers. All types have some pros and cons associated with them: ESCs have numerous
ethical issues associated with them, and aren’t guaranteed to be a perfect immune
match with the patient, requiring the patient to take immunosuppressants. ASCs can be
more difficult to both retrieve and proliferate to number large enough for seeding
applications. iPSCs still have little clinical data, and may potentially by
teratocarcinogenic, causing tumors. (Riha, Lin, Lumsden, Yao, & Chen, 2005)
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3 Phases of Graft Failure.
There are 3 distinct phases of graft failure; Early stage failure occurs within 30
days of surgery and is usually related to surgical complications, acute thrombosis, or
flow disturbances. Midterm failure is 3 months to 2 years, caused by neointimal
hyperplasia, obstructing the lumen, and late term failure is more than 2 years and
caused by atherosclerotic degradation. (Catto, Fare, Freddi, & Tanzi, 2014)
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AIM 1: MECHANICAL PROPERTIES OF PORATED ARTERIES
Methods
Tissue Preparation
Arteries are obtained from Animal Tech (Texas), and shipped on ice. The arteries
are porcine carotid arteries that were obtained from pigs slaughtered the previous day.
The arteries are placed in saline solution on ice. Using hands and scissors, the arteries
had all extraneous fat or branches trimmed off, taking care not to inadvertently
puncture or damage the artery. Arteries had all blood or blood clots removed, until
tissue no longer appeared red. Samples were set aside and frozen at -80 °C for DNA
extraction with other samples being placed in 10% formalin for histology. Arteries were
mounted with barbed Luer adaptors on each side, using zip ties to secure. Using a
syringe with a Luer connection push saline through the artery to clean and locate any
branches or holes are. All identified openings were sutured shut, and the arteries were
re-infused with saline to verify that they were all shut. Arteries were put into 30 mM
EDTA, 0.02% Sodium Azide with pH of 7 (overnight solution) overnight in refrigerator.
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Decellularization

Figure 5: Decellularization system, containing 2 elevated chambers acting as dampeners for fluid coming from
peristaltic pump, and to assist in generating a suitable pressure differential across arteries, 2 lower chambers used for
fluid changes, the arterial chamber to house the arteries and allow fluid to flow both through and around them, and a
peristaltic pump to provide adequate fluid flow. (Ferreira, 2015)

The decellularization circuit was assembled as described in (Fercana, et al., 2014)
creating two parallel circuits with a volume of ~1.4 L. Appropriately sized Luer barbed
adaptors were used to equip each circuit with 6 arteries. The system was then filled
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with overnight solution. And run with pressure (~50 mmHg) then rinsed using ddi water
procedure (Rinse using ~5 L of ddi water without pressure, then 2.5 L with pressure).
Decellularization began 1% SDS run with pressure for 6 days,
then drained and replaced with fresh 1% SDS solution for
another 6 days. Another ddi water rinse protocol was
conducted, followed by 3 separate 1 L infusions of 70%
ethanol into each separate circuit. Each was spaced an hour
apart. Then one more ddi water rinse performed, while
using ddi water as a 30 minute with pressure. Ddi water was

Decellularize
Acetic Acid (1 Hr)
Lyophilization
Derma-rolling
Sterilization
Store
Acetic Acid

drained, and 0.1M NaOH solution was introduced and run
for 2 Hours, then followed by another ddi water rinse cycle.
Following the rinse cycle was introduction of 1x PBS which
was run with pressure overnight. Next system was drained

Lyophilization
Seeding
Figure 6: flow chart of major steps
going from decellularization to cell
seeding.

and then filled with DNAse/RNAse solution (720 mUnits/mL DNAse, 720 mUnits/mL
RNAse, 5mM MgCl, 1% antibiotic/antimycotic in 1x PBS adjusted to pH 7.5) Was run
with DNAse/RNAse solution for 96 hours. Next 1x PBS was introduced and run with
pressure for 1 hour. To conclude decellularization process, conduct 3 separate ddi water
rinse protocols with system running for ~20 minutes in between rinse steps. If any
decellularized scaffolds were needed for histology/DNA analysis they were removed
here, and replaced with tubing.
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DNA Extraction
When artery samples were taken, small sections were placed in microcentrifuge
tubes and stored at -80 °C until electrophoresis is performed. Electrophoresis was
performed using fresh and decellularized (not acetic acid treated) samples. The samples
were weighed to ensure they were less than 25 mg, and the values were recorded for
quantification during the nanodrop. The <25 mg sample was placed into 1.5 mL
microcentrifuge tube, and filled with 180 µL Buffer ATL and 20 µL of proteinase K.
Incubate at 56 °C until tissue is completely lysed. Once lysed vortex for 15seconds, then
add 200 µL Buffer AL and mix by vortexing. Next 200 µL of ethanol was added then
mixed by vortexing. The mixture was pipetted into a DNeasy Mini spin column placed in
a 2 mL collection tube. Centrifuge at 8000 rpm for 1 min. flow through was discarded
along with collection tubes. Spin column placed into new 2 mL collection tube, and 500
µL buffer AW1. The tube was then centrifuged at 1 min at 8000 rpm. Flow through and
collection tubes was discarded. It was then placed in a new collection tube with 500 µL
of Buffer AW2 and centrifuged for 4 minutes at 13.2 rpm. It was then transferred to a
new collection tube. DNA was eluted using 200 µL Buffer AE incubate for 1 min at room
temperature. Then centrifuge for 1 minutes at 8000 rpm. Repeat step with buffer AE for
increased DNA yield.
Nanodrop
Using the extracted DNA, a quantitative analysis was performed using Nanodrop
2000 Spectrophotometer (Thermo Scientific). First it was cleaned with DNA/RNA free
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water, then buffer AE was ran as a control, followed by each sample of DNA. The stand
was cleaned with DNA/RNA free water in between each measurement. Using the data,
the amount of DNA was calculated and used with the weight of the tissue to determine
DNA concentration in ng DNA/mg tissue.
Decellularization Results

Figure 7: Concentration of DNA in tissue as determined by spectrophotometer
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Figure 8: image of gel electrophoresis showing the size of DNA present in fresh and decellularized samples
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Lumen

Lumen

Lumen

Lumen

Figure 9: Histology of Fresh and decellularized tissue with H&E and DAPI. Nuclei are purple in H&E and bright blue in
DAPI

Gel Electrophoresis
10x TBE buffer was prepared with 21.8 g TRIS, 11 1 g boric acid, 0.93 g EDTA, pH
of 8.3 and brought to 200 mL with ddi water. Electrode buffer was prepared with 75 mL
of 10x TBE buffer and 1425 mL of distilled deionized (ddi) water. Agarose gel was
prepared using 100 mL 0.5x TBE and 1 g of agarose.
Agarose gel was placed in microwave for 1.5 minutes stopping every 30 second
to stir. Allow gel to cool to 60 °C then add 5 µL of ethidium bromide, then pour gel into
mold and place comb.
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Prepare samples and standards by adding 8 µL of fluorescent dye into 32 µL of
each sample. For the DNA ladder, use five parts DNA ladder and one-part dye. Load 20
µL of each sample into wells, then run at 100 V for 1 hour. Then image the gel using
ChemiDoc XRS+ molecular imager with image lab software (Bio-Rad, Berkeley, Ca)
Embedding
Arteries were stored in 10% buffered formalin for 24+ hours. Sections of arteries
were run in a tissue processor overnight, and embedded in paraffin wax. Then embed
the tissue section in a block of wax in such a position that each section drawn from the
block shows a cross section of the artery. Sections are then cut at 10 microns using a
microtome, and placed onto the slides and then into an oven. Afterwards slides are
stored until histology.
Histology
Sections were deparaffinized with xylene and ethanol then stained with
Hematoxylin and Eosin (H&E) then dehydrated using ethanol and xylene, then equipped
with a coverslip and imaged at 10x and 2.5x magnification. The same was done using
Masson’s Trichrome stain to identify collagen, elastin, and glycosaminoglycans. 4',6diamidino-2-phenylindole (DAPI) was used as a fluorescent stain to identify nuclei.
Imaging was done with Axiovert 40 CFL microscope equipped with Axiocam mRC and
Axiovision image software (Carl Zeiss)
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Poration Methods
To begin the chemical poration, 0.2 M acetic acid was added to system and run
with pressure for 1 hour. Then system was drained and arteries were removed and
placed into 50 mL conical tubes which were then placed into -80 °C. The 50 mL conical
tubes were then placed into lyophilization flask lyophilized for 72 hours. Following
lyophilization scaffolds were removed and placed into 5% CO2 incubator for 6 hours for
partial rehydration. Scaffolds were then set onto cutting mat and rolled along the main
axis 10x on each side using 1 mm derma-roller. Scaffolds were then set into container
with ddi water and allowed to rehydrate overnight.
Samples were then set into sterile 0.1% v/v Peracetic acid solution in 1x PBS.
Containers were covered in foil and set onto shaker plate for 4 hours. Following
sterilization, arteries were placed into sterile ddi water containing 1%
antibiotic/antimycotic and stored until used in refrigerator at 4 °C.
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Poration results

Figure 10: Average pore size of fresh, 1 hour, and 3-hour acetic acid treated. Dry is tissue dried through lyophilization,
and wet refers to tissue rehydrated after lyophilization
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Lumen

Lumen

Lumen

Lumen

Lumen

Lumen

Figure 11: H&E and DAPI images of the same fresh and decellularized tissue as in figure 8, but contrasted with a 1hour acetic acid treated scaffold. AA is acetic acid treated scaffolds

Compliance Methods
Connect the arteries were equipped with Luers and zip ties to secure them and
connected to pump and reservoir to achieve pressures of 80 mmHg and 120 mmHg.
Arteries were set into Pyrex container and on countertop system was adjusted to 80
mmHg, the Pyrex dish was lowered to achieve a pressure of 120 mmHg. Pressure was
measured using PDAQview software and 50 psi transducer. A ruler was placed on the
Pyrex dish, a picture was taken containing both ruler and artery at 80 mmHg and 120
mmHg. After testing a small section of the artery was cut, and a picture was taken with
it and the ruler. Using ImageJ and the ruler as a reference, Outer diameter at 80 and 120
mmHg were calculated, along with wall thickness and resting Internal diameter, these
values were then used to calculate the compliance for each arterial sample.

21

Burst Pressure Methods
The same experimental set up was used as when compliance was done, just
using a 100 PSI transducer instead of 50 PSI. The arteries were equipped with burst
pressure Luer adaptors and zip tied and ligated using 3.0 sutures. The system was
pressurized to the highest rpm the peristaltic pump could obtain. Pump was run for 1
minute then pressure recording was stopped. Burst pressure was obtained by finding
the max pressure in the samples.
Result

Figure 12: burst pressure values for saphenous vein, Internal mammary artery, fresh porcine carotid, decellularized,
and 1 and 3-hour acetic acid treated. (Pashneh-Tala, Macneil, & Claeyssens, 2016) (Roy, Silacci, & Stergiopulos, 2005)
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Figure 13: compliance values of Internal mammary artery and saphenous vein along with decellularized, 1 and 3-hour
acetic acid treated arteries. (Pashneh-Tala, Macneil, & Claeyssens, 2016)

Discussion
As shown in in Figure 8, you can see the substantial number of cells present in
fresh tissue, and the complete lack of those cells in the decellularized images. The
amount of DNA present, as determined by spectrophotometer, in the scaffolds is
around 50 ng DNA/mg tissue which is considered sufficiently decellularized in literature.
(Crapo, Gilbert, & Badylak, 2011). The gel electrophoresis clearly depicts that the fresh
samples had large DNA fragments, which is reasonable considering nothing had been
done to the fresh samples to damage or breakdown the DNA. The decellularized lanes
displayed no indicators of any DNA presence. The H&E and the DAPI stains on the
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decellularized scaffolds showed no cells present anywhere in the scaffold. This leads to
the conclusion that the decellularization procedure is effective in removing all the cells
from the scaffold.
The histology in figure 11 the increase in opens pores for cells to potentially
migrate into is apparent. The chart in figure 10 displays a quantitative visual analysis
showing the substantial increase in porosity from the acetic acid treatment.
The burst pressure of the decellularized and acetic acid treated scaffolds is much
lower than the burst pressure of native arteries. This doesn’t preclude them from being
suitable grafts however, because their burst pressures are still many times higher than
the systolic pressure of even a hypertensive patient (>160 mmHg) (American Heart
Association, 2016).
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AIM 2: CELL SEEDING STUDIES
Methods
Cells
Rat adipose derived stem cells were thawed and began culture in T75 cell culture
flask, at passage 20, cells were fed media consisting of Dulbecco’s Modified Eagle
Medium (DMEM) with 10% Fetal Bovine Serum (FBS), and 1% antibiotic/antimycotic and
expanded to a total of 12 million cells.

1st Cell Seeding
Luer barbed adaptors, forceps, were sterilized the day before. Using the
sterilized arteries from in 1x PBS from earlier, Arteries were placed in 0.2 M acetic acid
again for 2 hours, then lyophilize the arteries again sterile. Scaffolds were equipped with
a Luer adaptor on each end, and 6 arteries were injected with 1 mL of 2.02 million cells
per ml. Arteries were placed in T175 flasks filled halfway with media, and left into
incubator for 2 days.
DAPI & L/D
Two arteries used for DAPI and Live Dead staining. The DAPI was composed of 3
mL DPBS and 3 µL of DAPI stain. The Live Dead stain was composed of 3 mL DPBS, 1.5 µL
calcein AM, and 6 µL ethidium homodimer-1. Sections of arteries were immersed in the
stains for 30 minutes, and were insulated from light using aluminum foil. Images taken
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using Axiovert 40 CFL microscope equipped with Axiocam mRC and Axiovision image
software (Carl Zeiss)

Results
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Figure 14: H&E and DAPI images of fresh decellularized and cell seeded tissue

2nd Cell Seeding
Arteries were decellularized and porated and sterilized as described earlier.
Again, rat ADSCs were cultured and expanded. Arteries were set into sterile acetic acid

Figure 15: Diagram depicting the difference in the groups for cell rolled versus noncell rolled samples.
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for 1 hour, then placed into 50 ml conical tubes and put in -80 °C freezer overnight.
They were then lyophilized sterilely for 48 hours. Arteries were placed in a petri dish
containing ~50 million cells suspended in 30 ml of media (DMEM, 10% FBS, 1% ab/am).
They were then placed in incubator for 2 hours for the cells to settle. Arteries were then
removed from incubator and rolled 10x on each side with the derma-roller. Arteries
then placed into T175 flasks, filled approximately halfway, and set into incubator for 7
days. Arteries then removed and used for Live/Dead, DAPI, and histology.
2nd Seeding Results

Figure 16: Live and Dead images at 10x and 2.5x of cell rolled and noncell rolled scaffolds. Bright green indicates live
cells, and bright red indicates dead cells.
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Figure 17: DAPI images at 10x and 2.5x of cell rolled and noncell rolled scaffolds. Bright blue indicates cells.
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Figure 18: Masson's Trichrome stain of cell rolled and noncell rolled scaffolds. Red indicates elastin, blue indicates
collagen, and yellow indicates GAG's.
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Figure 19: H&E stain of cell rolled and noncell rolled. dark purple indicates nuclei of cells
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Figure 20: Bar graph showing the average and standard deviation of cells counted from Live and DAPI images in cell
rolled and noncell rolled samples.

3rd Cell Seeding
Arteries were again decellularized in the same manner as described above, then
treated with acetic acid and left in -80 °C overnight. Arteries then lyophilized for ~2
days. Seeding used 3 cell lines, human aortic endothelial cells (hAECs) starting from
passage 1 and using endothelial growth media (EGM) (Lonza), human aortic adventitial
fibroblasts (hAoAF) at passage 6 fed with media made of 1%antibiotic/antimycotic, 10%
FBS, and 89% DMEM. The third cell line was human aortic smooth muscle cells
(hASMC’s) started at passage 4 grown in smooth muscle growth media (SGM) (Lonza).
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Arteries were set in incubator for 6 hours, then derma-rolled 10x on each side with 1
mm derma-roller, and then set into ddi water overnight. Arteries were then lyophilized
again for 2 days.
hASMC Seeding
43 million cells were split into 4 petri dishes containing 3 mL of SGM for 10.7
million cells in each dish, and an average cell density of 0.357 million cells per mL media.
Eleven sterilized arteries were removed and placed into petri dishes with 2 containing 3
arteries and 2 containing 2 arteries. There was a noticeable color change when the
arteries were placed in the media, indicating a pH change. They were then set into
incubator for 1 hour at 37 °C at 5% CO2. Arteries were placed into petri dish and dermarolled 10x on each side with 1 mm derma-roller. Afterwards, arteries placed into T175
flask and filled with 50 mL SGM. Arteries were placed on an orbital shaker inside of an
incubator for 5 days with SGM changes every other day.
hAEC and hAoAF Seeding
The T175 flasks were removed from incubator, and then arteries removed using
sterile forceps. Both ends of the artery were equipped with Luer barbed adaptors, with
one end of each being also equipped with a Luer cap. Using a 1 mL Luer lock syringe, 1
mL of media containing 10.5 million hAECs, was injected into the lumen of the artery.
The syringe was removed, and each artery was carefully placed back into a new T175
flask, with care taken not to allow cell suspension to leak out into flask. Then T175s
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were put back into incubator (without shaker) for 2 hours to give the HAECs time to
attach. Next the T175s were removed once more to be seeded with hAoAFs. Using a 5
mL serological pipette, 1 mL of media containing 0.815 million hAoAFs was slowly
dropped onto the adventitial layer of each artery. After each artery has been seeded,
the flasks were put back into incubator (no shaker) overnight. The next morning 25 mL
of media (1% antibiotic/antimycotic, 10% FBS, 89% DMEM) was added and shaker was
turned on at a low speed. They were left in incubator for 1 week then removed and
imaged with Live/Dead, DAPI, and immunofluorescence.
Immunofluorescence
Arteries were fixed in 4% paraformaldehyde or 10% neutral buffered formalin.
For ~24 hours. Processed with a tissue processor, and then embedded in paraffin blocks.
Blocks were sectioned and placed onto slide, with 2 sections per slide, and baked in
oven overnight. Slides were deparaffinized, and then immersed in 10 mM citric acid at
90 °C for 30 minutes, then cooled to room temperature for 30 minutes, and immersed
into distilled water. Sections on the slides were circumscribed with a wax pen, the wet
with 1x PBS. PBS was removed and then 0.3% Triton in 1x PBS was placed for 10 minutes
at room temperature. Sections were then covered in blocking solution (1 % BSA, 2% FBS,
0.05% Triton in 1x PBS, filtered) for 2 hours at room temperature. The blocking solution
was removed and the primary antibody (for αSMA 0.5 µg/mL ab7817, for vimentin
5µL/mL ab92547, for CD31 5µL/mL Abbiotec 250589, all in 1:1 ratio of blocking solution
and 1x PBS) was placed onto the sections and left for 2 hours. The primary antibody was
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removed, slides rinsed 3 times with PBS, and the secondary antibody (Alexa Fluor 488
and 594, anti-rabbit/mouse accordingly, 4 µL/mL, in 1:1 ratio of blocking solution and 1x
PBS) was placed for 2 hours in the darkness. Then the antibody was removed and the
slides were cover slipped using Vectashield DAPI mounting media. Images taken using
Axiovert 40 CFL microscope equipped with Axiocam mRC and Axiovision image software
(Carl Zeiss)

Results

Lumen

Figure 21: Immunofluorescence stain using anti αSMA as primary and red Alexa Fluor 588 as the secondary, overlaid
with DAPI image
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Figure 22: Immunofluorescence stain using anti vimentin as primary and green Alexa Fluor 588 as the secondary,
overlaid with DAPI image
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Figure 23:Live image at 2.5x of 3rd cell seeding study

Discussion
From the first seeding, the scaffolds have a propensity for reseeding. In only two days,
noticeable cell attachment has occurred. Across several parts of the artery. In all the images
taken, it was expected to find some that would be indicative of damage done by the dermaroller to the artery. None of the images obtained displayed any sort of damage, which led to the
idea that the rehydration was allowing the elastin to be indented, and then “bounce back”
without any sort of opening generated to allow for the infiltration of cells.
This is what led to the second experiment. With the hypothesis that as cells were in
suspension, and partially attached during the derma-rolling procedure, it would help provide an
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avenue for the cells to infiltrate. As seen in the noncell rolled trichrome (Figure 18) and the cell
rolled H&E (Figure 19), there appears to be a straight-line puncture through all three layers of
the tissue. In the H&E picture, the cells are present along the crack edge. This supports the idea
the previous method of rehydration may have been insufficient. The trichrome is less effective
in displaying the presence of cells, but does show that the puncturing does not significantly alter
the make-up of the tissue. Both cell rolled and noncell rolled proved to be successful in cell
acquisition. In the future, this study could be repeated with just cell rolling and no injection to
try and quantify how many cells are coming from each seeding method, how much the method
is impacting the location cells attach to, and observe for a longer period. The graph in Figure 20
shows the mean and standard deviation of the cells counted from DAPI and live images. There
isn’t any significant difference between the two, and both sample sets had large variance. Using
a 2-tailed t-test, and n=12, the p-value was 0.899.
The third seeding incorporated hAECs, hASMCs, and hAoAFs to replicate the cells that
dominate the intimal, medial, and adventitial layers respectively. By using the cell rolled method
in a similar manner as was used in the previous experiment, muscle cells were expected to
migrate more into the medial layers of the scaffold. This can be seen in Figure 21 which depicts
the location of alpha Smooth Muscle Actin (αSMA), a common muscle cell marker. The presence
of red throughout the scaffold indicates that muscle cells had the ability to migrate throughout
all the layers. The vimentin stain has the fluorescence concentrated towards the adventitial
layer of the artery. This is largely because that’s the location of the seeding, and the hAoAFs had
less time to infiltrate into the scaffold. The CD31 stain was unsuccessful, and the imaging needs
to be reattempted. Those images could be very useful since the hAECs had the highest seeding
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density of any of the cell types. The live image depicts a near monolayer along the luminal
surface, which would be very promising. The results of this experiment merit repeating due to
the complications of the pH change during the hASMC seeding. The change is believed to be
from incomplete lyophilization which would have left some residual peracetic acid present in
the scaffold leftover from sterilization.
Future experiments based off these results could have a repeat of the 3rd seeding with 3
cell types, but taking one sample out for histology at various time points to observe the
migration of the cells. Future studies could also employ a bioreactor to observe the effect of the
pressure gradient on the recellularization, and any effects on the location of the different cell
types. Another study could attempt to differentiate endothelial, smooth muscle, and fibroblast
cells from adipose derived stem cells and use those in seeding the scaffold. This is more
replicative of how a tissue engineered scaffold would function practically. Eventually an animal
study could be done using pigs or rats to see if the seeded scaffolds can compare to just
decellularized scaffolds, or other graft materials.
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CONCLUSIONS
1) Decellularization and mechanical characterization
a. The compliance is within ranges of currently acceptable grafts, and the
burst pressure of the artery while lower than autologous vessels, is still
many times above standard blood pressures even in a hypertensive
patient
b. The decellularization shows ~50 ng DNA/mg tissue, the gel
electrophoresis displays no bands in the decellularized samples, and all
histology of decellularized scaffolds lacks any evidence of cells, ensuring
that the current decellularization procedure is effective at removing all
cells from the artery.
2) Cell seeding #1
a. The cells have shown that they will attach to the decellularized scaffold,
but there was little evidence to show actual infiltration.
3) Cell Seeding #2
a. There was evidence of the derma-rolling piercing through the scaffold,
and that cells were present throughout the crevice created.
b. There was no significant difference between the number of cells counted
in the Cell rolled and noncell rolled scaffolds.
c. The derma-rolling process did not significantly alter the overall structure
of the artery
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4) Cell Seeding #3
a. αSMA was present in all layers of the artery, including the medial layers
suggesting that the hASMCs could migrate into the medial layer.
b. The vimentin stain suggested the concentration of the hAoAFs in the
adventitial layer of the scaffold where they were seeded.
c. The CD31 stain was inconclusive and not displayed, another stain for the
hAECs needs to be done.
d. The live images showed evidence of a monolayer along the luminal
surface.
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